Biocytogen Unleashes Legions of High-Tech Mice to Lure IPO Investors
The major provider of gene-edited lab rodents gets the nod for a Hong Kong listing after abandoning a plan to float shares on Shanghai’s STAR Market Key Takeaways: Gene-edited lab…
RECENT ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK 57.20 (+1.7%) -
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK 147.40 (-9.2%) ONC.US 254.49 (-4.7%) 688235.SHG 236.10 (-7.3%)
- Cancer drug maker Genfleet joins Hong Kong IPO influx
